Provided by Tiger Trade Technology Pte. Ltd.

COSMOS HEALTH INC

0.2559
+0.00090.35%
Volume:1.16M
Turnover:295.17K
Market Cap:25.85M
PE:-0.41
High:0.2600
Open:0.2568
Low:0.2500
Close:0.2550
52wk High:1.32
52wk Low:0.1616
Shares:101.00M
Float Shares:78.78M
Volume Ratio:0.39
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6204
EPS(LYR):-0.6321
ROE:-104.00%
ROA:-18.42%
PB:1.25
PE(LYR):-0.40

Loading ...

Cosmos Health Signs Loi to Acquire Doc Pharma S.a., a European Gmp Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

THOMSON REUTERS
·
Jun 12

Press Release: Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Dow Jones
·
Jun 12

Cosmos Health secures 180-day extension to regain Nasdaq compliance

TIPRANKS
·
Jun 11

Cosmos Health wins Nasdaq extension to meet $1 minimum bid price by Dec. 7, 2026

Reuters
·
Jun 11

Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance

THOMSON REUTERS
·
Jun 11

Cosmos Health: Does Not Intend to Effect Reverse Stock Split Unless Necessary to Maintain Its Nasdaq Listing

THOMSON REUTERS
·
Jun 11

Cosmos Health Unit Signs 3-Year Manufacturing Deal With Verisfield

MT Newswires Live
·
Jun 11

Cosmos Health Signs 3-Year Contract Manufacturing Agreement With Verisfield for 3.9 Million Units of Vasclor Gest Progesterone Pessaries

THOMSON REUTERS
·
Jun 11

Cosmos Health unit Cana signs 3-year deal to make 3.9 million VASCLOR GEST progesterone pessaries for Verisfield

Reuters
·
Jun 11

Cosmos Health - Targets Over $200 Mln Revenue, $44.2 Mln Adj Ebitda, $92.3 Mln Equity by 2029

THOMSON REUTERS
·
Jun 10

Cosmos Health - Expects FY2026 Revenue to Surpass $90 Mln, up 38% Year-Over-Year

THOMSON REUTERS
·
Jun 10

Cosmos Health projects FY2029 revenue of $200.6 million, adjusted EBITDA $44.2 million

Reuters
·
Jun 10

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

GlobeNewswire
·
Jun 10

Cosmos Health unit wins contract manufacturing agreement with Provident Pharma

TIPRANKS
·
Jun 10

Cosmos Health unit Cana signs 5-year Provident deal to make 385,000 CERTORUN units

Reuters
·
Jun 10

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line With New 5-Year Contract Manufacturing Agreement With Provident Pharmaceuticals for 385,000 Units of Certorun

THOMSON REUTERS
·
Jun 10

Cosmos Health unit acquires international patent application WO2025108566A1 from Cloudpharm

Reuters
·
Jun 08

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

THOMSON REUTERS
·
Jun 08

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

GlobeNewswire
·
Jun 05

Cosmos Health secures EU-wide distribution for Sky Premium Life via Skroutz

Reuters
·
Jun 05